Author = Hanan Selim Musallam
Number of Articles: 2
Is There any Benefit of Addition of Neo-Adjuvant Chemotherapy (FOLFOX4) to Standard Preoperative Treatment of Rectal Cancer? A Randomized Clinical Trial

Volume 25, Issue 7, July 2024, Pages 2457-2466

Hanan Selim Mosallum; Omar ElFarouk Osman Zaki; Heba Ashraf Hosni; Hussein Mohamed Metwally

Triplet (FOLFOXIRI) Versus Doublet (FOLFOX or FOLFIRI) Regimen as First Line Treatment in Metastatic Colorectal Carcinoma, a Prospective Phase II, Randomized Controlled Trial

Volume 23, Issue 10, October 2022, Pages 3421-3429

Khaled Ahmed Khalil; Hanan Selim Musallam; Mohamed Abdulla Hassan; Inas Abdou Mahmoud

Asian Pacific Journal of Cancer Prevention

Journal Archive